Apitoria Pharma Pvt Ltd's API manufacturing facility classified as VAI by USFDA

The U.S. Food and Drug Administration (US FDA) had conducted an inspection at the Unit-V, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, situated at Pashamylaram Village, Patancheru Mandal, Sanga Reddy District, Telangana from December 09 to December 17, 2024.

The Unit has now received Establishment Inspection Report classifying the facility as "Voluntary Action Indicated" ("VAI").

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1137.15 as compared to the previous close of Rs. 1112.90. The total number of shares traded during the day was 15983 in over 1262 trades.

The stock hit an intraday high of Rs. 1138.85 and intraday low of 1118.45. The net turnover during the day was Rs. 18061079.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 ApitoriaPharma USFDA APIManufacturingFacility Classification VAI